Dabrafenib — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

7 Recruiting

3 Completed trials

9 Sponsors

6 Countries

Phase II

Phase III: 1 Phase II: 11

Oversight events:

1 serious breach 2 urgent safety measures across 2 trials

View oversight register →

Sponsors using this IMP

Region Hovedstaden 3 Oslo University Hospital HF 2 Akershus University Hospital 1 Centre Leon Berard 1 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 1 HUS-Yhtymae 1 Institut National De La Sante Et De La Recherche Medicale 1 Leids Universitair Medisch Centrum (LUMC) 1 Region Skane 1

All trials

12 total

NEOAC Pending

2024-516126-54-00 Phase II 1 country Leids Universitair Medisch Centrum (LUMC)
Molecularly Tailored Therapy versus Standard Care in Advanced Pancreatic Cancer Pending

2025-522431-34-00 Phase II 1 country Region Hovedstaden
Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting

2024-513779-42-02 Phase II 1 country Oslo University Hospital HF
FINPROVE - The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Recruiting

2024-517478-68-01 Phase II 1 country HUS-Yhtymae
Neoadjuvant and postoperative treatment with dabrafenib and trametinib for papillary craniopharyngioma Recruiting

2024-517611-67-00 Phase II 1 country Region Skane
Improving public cancer care by implementing precision medicine in Norway Recruiting

2023-507894-16-00 Phase II 1 country Oslo University Hospital HF
Clinical trial evaluating the value of treatment with therapy specifically targeting the molecular alterations identified in the tumor of pa… Recruiting

2023-510567-35-00 Phase II 1 country Centre Leon Berard
Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids. The MEMBRAINS trial Recruiting

2024-516585-11-00 Phase II 1 country Region Hovedstaden
DRUP trial Recruiting

2023-509152-33-00 Phase II 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
A clinical trial on an individualized treatment strategy for patients with metastatic non-clear cell kidney cancer Ended

2024-519070-39-00 Phase II 1 country Region Hovedstaden
MULTISARC : MOLECULAR PROFILING OF ADVANCED SOFT-TISSUE SARCOMAS. A phase III study Ended

2024-514873-22-00 Phase III 1 country Institut National De La Sante Et De La Recherche Medicale
Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized … Ended

2023-509092-16-00 Phase II 1 country Akershus University Hospital

Showing 1–12 of 12 trials

← All drugs A–Z